Delivery Order SPE2DB20D1004-SPE2DB25FNLCE
- Not listed
- The Defense Logistics Agency awarded a $3,027.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine product, with an ultimate completion date of September 15, 2025. The delivery order, issued on September 12, 2025, is a non-set-aside award executed under a competitive procurement process. AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its primary location. This delivery order...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply, valued at $18,567.90 under a firm fixed price structure. This non-set-aside award was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $1,495.76 firm fixed-price delivery order for Engerix-B 10 microgram vaccine (10-count) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, non-set-aside contract was issued under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated as SPE2DX. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine at a ceiling value of $1,435.25. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement practices. The work is performed at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of September 11, 2025. This delivery order is executed under...
- The Defense Logistics Agency awarded a $1,607.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply, with performance in Conshohocken, Pennsylvania and completion targeted for June 17, 2025. This non-set-aside competitive award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,359.98 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine (hepatitis B vaccine) on September 22, 2025, with completion targeted for September 23, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $22,886.40 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine supply. This firm fixed price contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $24,284.58 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, was competitively awarded without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the...
- The Defense Logistics Agency awarded a delivery order valued at $1,751.90 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,334.40 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes under a firm fixed price contract. This non-set-aside award was made on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNLCEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,469.50 of Engerix-B 20 MCG/ML vaccine on September 29, 2025, with completion scheduled for September 30, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's extensive contract portfolio with the DLA demonstrates its capability to meet federal procurement requirements across diverse therapeutic domains. The Engerix-B vaccine delivery under this order supports the military medical supply chain's immunization programs, consistent with AmerisourceBergen's role as a primary vendor for vaccines and specialty pharmaceutical products across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 9/29/25 |